Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Wands J. Hepatocellular carcinoma and sex. N Engl J Med. 2007;357(19):1974–1976.
   PubMed Web of Science ®Google Scholar
• Liu P, Xie SH, Hu S, et al. Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States. Oncotarget. 2017;8(40):68131–68137.
   PubMedGoogle Scholar
• Yeh SH, Chen PJ. Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology. 2010;78(Suppl 1):172–179.
   PubMedGoogle Scholar
• Qiu S, Vazquez JT, Boulger E, et al. Hepatic estrogen receptor alpha is critical for regulation of gluconeogenesis and lipid metabolism in males. Sci Rep. 2017;7(1):1661.
   PubMedGoogle Scholar
• Jordan VC. The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer. Endocr Relat Cancer. 2015;22(1):R1–31.
   PubMed Web of Science ®Google Scholar
• Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121–124.
   PubMed Web of Science ®Google Scholar
• Shen M, Estradiol SH. Estrogen receptor agonists oppose oncogenic actions of leptin in HepG2 cells. PLoS One. 2016;11(3):e0151455.
   PubMed Web of Science ®Google Scholar
• Xu Z, Liu J, Jianxin C, et al. 17beta-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor. J Cell Biochem. 2018;119(10):8659–8671.
   PubMed Web of Science ®Google Scholar
• LaCroix AZ, Chlebowski RT, Manson JE, et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA. 2011;305(13):1305–1314.
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472): 1687–1717. .
   PubMed Web of Science ®Google Scholar
• Ellis MJ, Gao F, Dehdashti F, et al. Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study. JAMA. 2009;302(7):774–780.
   PubMed Web of Science ®Google Scholar
• Ryu WS, Kim JH, Jang YJ, et al. Expression of estrogen receptors in gastric cancer and their clinical significance. J Surg Oncol. 2012;106(4):456–461.
   PubMed Web of Science ®Google Scholar
• Fan P, Griffith OL, Agboke FA, et al. c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells. Cancer Res. 2013;73(14):4510–4520.
   PubMed Web of Science ®Google Scholar
• Mobley JA, Brueggemeier RW. Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis. 2004;25(1):3–9.
   PubMed Web of Science ®Google Scholar
• Shen M, Cao J, Shi H. Effects of estrogen and estrogen receptors on transcriptomes of HepG2 cells: a preliminary study using RNA sequencing. Int J Endocrinol. 2018;2018:5789127.
   PubMed Web of Science ®Google Scholar
• Pinnix ZK, Miller LD, Wang W, et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med. 2010;2(43):43ra56.
   PubMed Web of Science ®Google Scholar
• Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013;13(5):342–355.
   PubMed Web of Science ®Google Scholar
• Bajbouj K, Shafarin J, Abdalla MY, et al. Estrogen-induced disruption of intracellular iron metabolism leads to oxidative stress, membrane damage, and cell cycle arrest in MCF-7 cells. Tumour Biol. 2017;39(10):1010428317726184.
   Google Scholar
• Hamad M, Bajbouj K, Taneera J. The case for an estrogen-iron axis in health and disease. Exp Clin Endocrinol Diabetes. 2019. DOI:10.1055/a-0885-1677
   Web of Science ®Google Scholar
• Zhou L, Zhao B, Zhang L, et al. Alterations in cellular iron metabolism provide more therapeutic opportunities for cancer. Int J Mol Sci. 2018;19:5.
   Web of Science ®Google Scholar
• Yang Q, Jian J, Katz S, et al. 17beta-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology. 2012;153(7):3170–3178.
   PubMed Web of Science ®Google Scholar
• Hou Y, Zhang S, Wang L, et al. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene. 2012;511(2):398–403.
   PubMed Web of Science ®Google Scholar
• Qian Y, Yin C, Chen Y, et al. Estrogen contributes to regulating iron metabolism through governing ferroportin signaling via an estrogen response element. Cell Signal. 2015;27(5):934–942.
   PubMed Web of Science ®Google Scholar
• Bajbouj KJS, Hamad M. Estrogen-dependent disruption of intracellular iron metabolism augments the cytotoxic effects of doxorubicin in select breast and ovarian cancer cells. Cancer Manag Res. 2019;11:4655–4668.
   PubMed Web of Science ®Google Scholar
• van der Weijden VA, Floter VL, Ulbrich SE. Gestational oral low-dose estradiol-17beta induces altered DNA methylation of CDKN2D and PSAT1 in embryos and adult offspring. Sci Rep. 2018;8(1):7494.
   PubMedGoogle Scholar
• Schwarz JM, Nugent BM, McCarthy MM. Developmental and hormone-induced epigenetic changes to estrogen and progesterone receptor genes in brain are dynamic across the life span. Endocrinology. 2010;151(10):4871–4881.
   PubMed Web of Science ®Google Scholar
• Anderson GJ, Frazer DM. Current understanding of iron homeostasis. Am J Clin Nutr. 2017;106(Suppl6):1559S–66S.
   PubMedGoogle Scholar
• Hamad M, Bajbouj K, Taneera J. The case for an estrogen-iron axis in health and disease. Exp Clin Endocrinol Diabetes. 2020;128(4):270–277.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Tajima S, Izawa-Ishizawa Y, et al. Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes. PLoS One. 2012;7(7):e40465.
   PubMed Web of Science ®Google Scholar
• Hua K, Din J, Cao Q, et al. Estrogen and progestin regulate HIF-1alpha expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway. Oncol Rep. 2009;21(4):893–898. .
   PubMed Web of Science ®Google Scholar
• Kazi AA, Molitoris KH, Koos RD. Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus. Biol Reprod. 2009;81(2):378–387.
   PubMed Web of Science ®Google Scholar
• Pentecost BT, Teng CT. Lactotransferrin is the major estrogen inducible protein of mouse uterine secretions. J Biol Chem. 1987;262(21):10134–10139.
   PubMed Web of Science ®Google Scholar
• Stuckey R, Aldridge T, Lim FL, et al. Induction of iron homeostasis genes during estrogen-induced uterine growth and differentiation. Mol Cell Endocrinol. 2006;253(1–2):22–29.
   PubMed Web of Science ®Google Scholar
• Yasar P, Ayaz G, User SD, et al. Molecular mechanism of estrogen-estrogen receptor signaling. Reprod Med Biol. 2017;16(1):4–20.
   PubMed Web of Science ®Google Scholar
• Palierne G, Fabre A, Solinhac R, et al. Changes in gene expression and estrogen receptor cistrome in mouse liver upon acute E2 treatment. Mol Endocrinol. 2016;30(7):709–732.
   PubMedGoogle Scholar
• Surani MA, Hayashi K, Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell. 2007;128(4):747–762.
   PubMed Web of Science ®Google Scholar
• Joh RI, Palmieri CM, Hill IT, et al. Regulation of histone methylation by noncoding RNAs. Biochim Biophys Acta. 2014;1839(12):1385–1394.
   PubMed Web of Science ®Google Scholar
• Johnson LM, Bostick M, Zhang X, et al. The SRA methyl-cytosine-binding domain links DNA and histone methylation. Curr Biol. 2007;17(4):379–384.
   PubMed Web of Science ®Google Scholar
• Tamaru H, Zhang X, McMillen D, et al. Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat Genet. 2003;34(1):75–79.
   PubMed Web of Science ®Google Scholar
• Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev. 2005;15(5):490–495.
   PubMed Web of Science ®Google Scholar
• Schotta G, Lachner M, Sarma K, et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 2004;18(11):1251–1262.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Rank G, Tan YT, et al. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing. Nat Struct Mol Biol. 2009;16(3):304–311.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu L, Ding J, et al. Iron Metabolism in Cancer. Int J Mol Sci. 2018;20:1.
   Web of Science ®Google Scholar
• Pogribny IP, Tryndyak VP, Pogribna M, et al. Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents. Int J Oncol. 2013;42(5):1822–1832.
   PubMed Web of Science ®Google Scholar
• Sharp PA, Clarkson R, Hussain A, et al. DNA methylation of hepatic iron sensing genes and the regulation of hepcidin expression. PLoS One. 2018;13(5):e0197863.
   PubMed Web of Science ®Google Scholar
• Tao Y, Wu Q, Guo X, et al. MBD5 regulates iron metabolism via methylation-independent genomic targeting of Fth1 through KAT2A in mice. Br J Haematol. 2014;166(2):279–291.
   PubMed Web of Science ®Google Scholar
• Cuddihy AR, O’Connell MJ. Cell-cycle responses to DNA damage in G2. Int Rev Cytol. 2003;222:99–140.
   PubMedGoogle Scholar
• Shen Y, Li X, Dong D, et al. Transferrin receptor 1 in cancer: a new sight for cancer therapy. Am J Cancer Res. 2018;8(6):916–931.
   PubMed Web of Science ®Google Scholar
• Barrientos T, Laothamatas I, Koves TR, et al. Metabolic catastrophe in mice lacking transferrin receptor in muscle. EBioMedicine. 2015;2(11):1705–1717.
   PubMed Web of Science ®Google Scholar
• Babu KR, Muckenthaler MU. miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma. Sci Rep. 2019;9(1):1518.
   PubMedGoogle Scholar
• Biamonte F, Battaglia AM, Zolea F, et al. Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b/p53 axis. Cell Death Dis. 2018;9(12):1174.
   PubMedGoogle Scholar
• Yang DC, Jiang X, Elliott RL, et al. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells. Anticancer Res. 2002;22(3):1513–1524.
   PubMed Web of Science ®Google Scholar
• Cozzi A, Levi S, Corsi B, et al. Role of iron and ferritin in TNFalpha-induced apoptosis in HeLa cells. FEBS Lett. 2003;537(1–3):187–192.
   PubMed Web of Science ®Google Scholar
• Hassan MM, Botrus G, Abdel-Wahab R, et al. Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2017;15(11):1791–1799.
   PubMed Web of Science ®Google Scholar
• Harris HA, Katzenellenbogen JA, Katzenellenbogen BS. Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. Endocrinology. 2002;143(11):4172–4177.
   PubMed Web of Science ®Google Scholar
• Howell A, Osborne CK, Morris C, et al. ICI 182,780 (Faslodex): development of a novel, “pure” antiestrogen. Cancer. 2000;89(4):817–825.
   PubMed Web of Science ®Google Scholar
• Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol. 1987;196(2):261–282.
   PubMed Web of Science ®Google Scholar
• Muhammad JS, Nanjo S, Ando T, et al. Autophagy impairment by Helicobacter pylori-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis. Int J Cancer. 2017;140(10):2272–2283.
   PubMed Web of Science ®Google Scholar
• Tsukatani T, Suenaga H, Shiga M, et al. Rapid susceptibility testing for slowly growing nontuberculous mycobacteria using a colorimetric microbial viability assay based on the reduction of water-soluble tetrazolium WST-1. Eur J Clin Microbiol Infect Dis. 2015;34(10):1965–1973.
   PubMed Web of Science ®Google Scholar